skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

4 Total results for product and free and sample content found

Scrip

Not To Be Sniffed At: Dupixent Success In Rhinosinusitis Could Open Up Large Additional Market

By Alexandra Shimmings 27 Nov 2020

Not To Be Sniffed At: Dupixent Success In Rhinosinusitis Could Open Up Large Additional Market

On the brink of an expanded US approval for asthma, Sanofi/Regeneron’s interleukin-4 receptor blocker Dupixent has produced positive topline Phase III data in a lucrative third indication, rhinosinusitis with nasal polyps.

Topic Influenza Virus

Scrip

Real-World Evidence Sought In Sanofi Pasteur Observational Flu Vaccine Trial

By Sten Stovall 13 Jun 2019

Real-World Evidence Sought In Sanofi Pasteur Observational Flu Vaccine Trial

Vaccine maker Sanofi Pasteur and managed care group Kaiser Permanente have joined forces in an observational trial using electronic medical records from 1.6 million people to highlight the benefits of integrated big data.

Topic Clinical trials Influenza virus Vaccines

Biomedtracker, Datamonitor Healthcare

December 2018 National Influenza Week

10 Apr 2019

December 2018 National Influenza Week

3 – 9 December is National Influenza Vaccination Week, a national awareness week focused on highlighting the importance of influenza vaccination. In this free KOL Insight Interview excerpt from Datamonitor Healthcare, read what key opinion leaders from the UK and US in Infectious Diseases have to say about current efforts to combat influenza with seasonal influenza vaccines:

Topic Influenza virus Infectious diseases

Citeline

Rising to the Challenge: An Analysis of the Influenza Vaccine Landscape in Response to the Swine Flu Pandemic

By Gabrielle Gessner 07 Oct 2013

Rising to the Challenge: An Analysis of the Influenza Vaccine Landscape in Response to the Swine Flu Pandemic

The swine influenza pandemic in 2009/10 highlighted numerous challenges in providing effective influenza vaccine coverage.

Topic Influenza virus

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: